Comparison between Exhicon Events Media IPO and Sotac Pharmaceuticals IPO.
Exhicon Events Media IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Sotac Pharmaceuticals IPO is a SME Bookbuilding proposed to list at NSE SME.
| Exhicon Events Media IPO | Sotac Pharmaceuticals IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | BSE SME | NSE SME |
| Lead Managers | Share India Capital Services Pvt.Ltd. | Beeline Capital Advisors Pvt.Ltd. |
| Registrar | MUFG Intime India Pvt.Ltd. | Kfin Technologies Ltd. |
| Market Maker | Share India Securities Ltd. | Sunflower Broking Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Exhicon Events Media IPO is up to ₹19.01 Cr whereas the issue size of the Sotac Pharmaceuticals IPO is up to ₹31.64 Cr. The final issue price of Exhicon Events Media IPO is ₹64.00 per share and of Sotac Pharmaceuticals IPO is ₹111.00 per share.
| Exhicon Events Media IPO | Sotac Pharmaceuticals IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹61.00 per share | ₹105.00 per share |
| Issue Price (Upper) | ₹64.00 per share | ₹111.00 per share |
| Issue Price (Final) | ₹64.00 per share | ₹111.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 2000 shares | 1200 shares |
| Fresh Issue Size | 29,70,000 shares | 28,50,000 shares |
| Fresh Issue Size (Amount) | up to ₹19.01 Cr | up to ₹31.64 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 29,70,000 shares | 28,50,000 shares |
| Issue Size Total (Amount) | up to ₹19.01 Cr | up to ₹31.64 Cr |
Exhicon Events Media IPO opens on Mar 31, 2023, while Sotac Pharmaceuticals IPO opens on Mar 29, 2023. The closing date of Exhicon Events Media IPO and Sotac Pharmaceuticals IPO is Apr 05, 2023, and Apr 03, 2023, respectively.
| Exhicon Events Media IPO | Sotac Pharmaceuticals IPO | |
|---|---|---|
| Anchor Bid Date | Mar 28, 2023 | |
| Issue Open | Mar 31, 2023 | Mar 29, 2023 |
| Issue Close | Apr 05, 2023 | Apr 03, 2023 |
| Basis Of Allotment (Tentative) | Apr 11, 2023 | Apr 10, 2023 |
| Initiation of Refunds (Tentative) | Apr 12, 2023 | Apr 11, 2023 |
| Credit of Share (Tentative) | Apr 13, 2023 | Apr 12, 2023 |
| Listing date (Tentative) | Apr 17, 2023 | Apr 13, 2023 |
| Anchor Lockin End date 1 | May 10, 2023 | |
| Anchor Lockin End date 2 | Jul 09, 2023 |
Exhicon Events Media IPO P/E ratio is 8.08, as compared to Sotac Pharmaceuticals IPO P/E ratio of 132.14.
| Exhicon Events Media IPO | Sotac Pharmaceuticals IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials |
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 86.20 | 84.63 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 62.25 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 8.08 | 132.14 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹76.00 Cr. | ₹122.66 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 67.65% | 6.38% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 144.58% | 19.03% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 2.74 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Exhicon Events Media IPO Retail Individual Investors (RII) are offered 10,40,000 shares while in Sotac Pharmaceuticals IPO retail investors are offered 10,40,000 shares. Qualified Institutional Buyers (QIB) are offered 14,84,000 shares in Exhicon Events Media IPO and 5,70,000 shares in Sotac Pharmaceuticals IPO.
| Exhicon Events Media IPO | Sotac Pharmaceuticals IPO | |
|---|---|---|
| Anchor Investor Reserveration | 8,53,200 shares | |
| Market Maker Reserveration | 3,30,000 shares | 1,50,000 shares |
| QIB | 14,84,000 shares | 5,70,000 shares |
| NII | 4,46,000 shares | 4,28,400 shares |
| RII | 10,40,000 shares | 9,98,400 shares |
| Employee | ||
| Others | ||
| Total | 29,70,000 shares | 28,50,000 shares |
Exhicon Events Media IPO subscribed 1.95x in total, whereas Sotac Pharmaceuticals IPO subscribed 1.60x.
| Exhicon Events Media IPO | Sotac Pharmaceuticals IPO | |
|---|---|---|
| QIB (times) | 1.00x | 1.00x |
| NII (times) | 3.28x | 4.04x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 2.31x | 0.91x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 1.95x | 1.60x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
